Results 21 to 30 of about 1,844 (152)

Efficacy and Safety of Remimazolam in Endoscopic Sedation—A Systematic Review and Meta-Analysis

Frontiers in Medicine, 2021
Background: The aim of this systematic review and meta-analysis was to investigate the efficacy and safety of remimazolam in clinical endoscopic procedure sedation.Methods: The authors searched the databases of PubMed, Embase, and Cochrane Library for ...
Xianlin Zhu, Hongbai Wang, Su Yuan, Yinan Li, Yuan Jia, Zhe Zhang, Fuxia Yan, Zaiping Wang   +7 more
doaj   +1 more source

Anesthesia Management of a Liver Transplant Recipient with Remimazolam

Case Reports in Anesthesiology, 2023
Background. Intraoperative anesthetic requirements might be altered due to the modulated metabolic function in living donor liver transplant recipients. Remimazolam may provide appropriate anesthesia in patients with cirrhosis.
Takashi Kawasaki, Takafumi Oyoshi, Naoyuki Hirata   +2 more
doaj   +1 more source

Remimazolam-Based Anesthesia in Patients with Heart Failure Due to Mitral Regurgitation and Low Left Ventricular Function: A Case Series

Medicina, 2023
Background and Objectives: Remimazolam is a new ultrashort-acting benzodiazepine anesthetic. Remimazolam appears to be useful in patients with severe valvular disease because of its minimal cardiovascular impact.
Atsuhiro Kitaura, Hiroatsu Sakamoto, Shinichi Hamasaki, Shota Tsukimoto, Yasufumi Nakajima   +4 more
doaj   +1 more source

A population pharmacodynamic Markov mixed‐effects model for determining remimazolam‐induced sedation when co‐administered with fentanyl in procedural sedation

Clinical and Translational Science, 2021
The clinical effects of remimazolam (an investigational, ultra‐short acting benzodiazepine being studied in procedural sedation) were measured using the Modified Observer’s Assessment of Awareness/Sedation Scale (MOAA/S).
Jie Zhou, Laura Curd, Lauren R. L. Lohmer, Natalie Delpratt, Joachim Ossig, Frank Schippers, Thomas Stoehr, Virginia D. Schmith   +7 more
doaj   +1 more source

Remimazolam Anaphylaxis during Induction of General Anesthesia Confirmed by Provocation Test—A Case Report and Literature Review

Medicina, 2023
Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test.
Sangho Lee, Joyoung Park, Na Hei Kim, Halin Hong, Kyoung Hee Sohn, Hee Yong Kang, Mi Kyeong Kim, Ann Hee You   +7 more
doaj   +1 more source

Intraoperative responses of motor evoked potentials to the novel intravenous anesthetic remimazolam during spine surgery: a report of two cases

JA Clinical Reports, 2020
Background Remimazolam is a novel short-acting benzodiazepine characterized by metabolism independent from organ function. We report intraoperative MEP responses of two patients who underwent spine surgery under general anesthesia using remimazolam. Case
Takashi Kondo, Yukari Toyota, Soshi Narasaki, Tomoyuki Watanabe, Hirotsugu Miyoshi, Noboru Saeki, Yasuo M. Tsutsumi   +6 more
doaj   +1 more source

Remimazolam for anaesthesia or sedation [PDF]

Current Opinion in Anaesthesiology, 2020
Purpose of review Anaesthesia and sedation are ubiquitous in contemporary medical practice. Developments in anaesthetic pharmacology are targeted on reducing physiological disturbance whilst maintaining or improving titrateability, recovery profile and patient experience.
J Robert, Sneyd, Ann E, Rigby-Jones
openaire   +2 more sources

Remimazolam Anesthesia for Thyroid Surgery

Case Reports in Anesthesiology, 2023
Background. Critical upper airway obstruction, hematoma formation, and recurrent laryngeal nerve palsy have been reported as postoperative complications of thyroid surgery. Although remimazolam may reduce the risk of these complications, the efficacy of flumazenil with remimazolam has not been reported.
Sae Nakagawa, Tomoharu Shakuo, Sakurako Matsudo, Hiroaki Soda, Kenji Shida   +4 more
openaire   +3 more sources

Remimazolam Enables Faster Sedation Induction and Recovery Compared With Midazolam in Diagnostic Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial. [PDF]

United European Gastroenterol J
ABSTRACT Background and Aims Remimazolam, a new ultra‐short‐acting benzodiazepine, is a safe and effective option for procedural sedation. Nevertheless, to date, no study has directly compared remimazolam and midazolam in diagnostic upper gastrointestinal endoscopy. This study aimed to evaluate the efficacy and safety of remimazolam compared with those
Park Y, Lee JK, Lee KH, Kim T, Kang SH, Ahn DW, Kim SB, Kim SJ.   +7 more
europepmc   +2 more sources

Relationship between age and remimazolam dose required for inducing loss of consciousness in older surgical patients

Frontiers in Medicine
BackgroundRemimazolam is a new ultra-short-acting benzodiazepine for procedural sedation and general anaesthesia, characterised by rapid onset of action, quick recovery, and organ-independent metabolism.
Jin-Chao Song, Xiao-xi Wang, Xiang Fu, Wei Chen, Shu-heng Tang, Fang Deng, Hua Yang, Wen Liu   +7 more
doaj   +1 more source